SCHEMBL7695035

SCHEMBL7695035

Cc1ccccc1-c1nc(S(=O)(=O)c2ccccc2)c(C(N)c2cccc(OC(F)(F)F)c2)o1

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.36
TSHR P16473 2/20 0.36
KAT6A Q92794 1/20 0.35
TP53 P04637 4/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 3/20 0.34
KDM4E B2RXH2 3/20 0.34
PTGES2 Q9H7Z7 1/20 0.34
MEN1 O00255 1/20 0.34
GAA P10253 1/20 0.34
KMT2A Q03164 1/20 0.34
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
HTR6 P50406 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7699868 0.90 ALDH1A1 (0.37) ALDH1A1TSHRTP53MAPTHTT
SCHEMBL7696341 0.89 MAPT (0.44) ALDH1A1TSHRTP53MAPTHTT
SCHEMBL7697200 0.86 TP53 (0.42) ALDH1A1TSHRTP53MAPTHTT
SCHEMBL7702583 0.85 POLB (0.42) ALDH1A1TSHRTP53MAPTHTT
SCHEMBL7700429 0.84 ALDH1A1 (0.45) ALDH1A1TSHRTP53MAPTHTT
SCHEMBL7694382 0.83 ALDH1A1 (0.39) ALDH1A1TSHRTP53MAPTHTT
SCHEMBL7694405 0.83 S1PR1 (0.38) ALDH1A1TSHRTP53MAPTHTT
SCHEMBL7704672 0.80 MAPT (0.45) ALDH1A1TSHRTP53MAPTHTT
SCHEMBL7695041 0.80 TP53 (0.47) ALDH1A1TSHRTP53MAPTHTT
SCHEMBL7701098 0.79 ALDH1A1 (0.37) ALDH1A1TSHRTP53MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002100842-A1 SULFONYLOXAZOLAMINES AND THEIR USE AS 5-HT6 LIGANDS MERCK PATENT GMBH (DE) 2002-12-19 WO claimed
WO-2002100842-A1 SULFONYLOXAZOLAMINES AND THEIR USE AS 5-HT6 LIGANDS MERCK PATENT GMBH (DE) 2002-12-19 WO disclosed